Gastric emptying and disease activity in inflammatory bowel disease

European Journal of Clinical Investigation

Volumn 45, Issue 12, 2015, Pages 1234-1242

  Keller, Jutta ^a   Binnewies, Ulrich ^a   Rösch, Marie ^a   Juul Holst, Jens ^b   Beglinger, Christoph ^c   Andresen, Viola ^a   Layer, Peter ^a  

^a ISRAELITISCHES KRANKENHAUS   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Disease activity; Gastric emptying; Hormonal regulation; Hyperglycaemia; Inflammatory bowel disease; Motility

Indexed keywords

AMINOSALICYLIC ACID; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BUDESONIDE; CHOLECYSTOKININ; CYCLOSPORIN; GLUCAGON LIKE PEPTIDE 1; MERCAPTOPURINE; METHOTREXATE; NEUROHORMONE; OCTANOIC ACID C 13; PEPTIDE YY; PREDNISOLONE; ZIDOVUDINE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASES; FEMALE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INFLAMMATORY BOWEL DISEASE; MALE; MIDDLE AGED; MUCOSA; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; STOMACH EMPTYING; ULCERATIVE COLITIS; ADOLESCENT; AGED; BREATH ANALYSIS; CASE CONTROL STUDY; CROHN DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTPRANDIAL STATE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BREATH TESTS; CASE-CONTROL STUDIES; CHOLECYSTOKININ; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GASTRIC EMPTYING; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; MIDDLE AGED; PEPTIDE YY; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 84954320706     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12542     Document Type: Article

References (41)

1. Staniland JR, Ditchburn J, de Dombal FT. Clinical presentation of diseases of the large bowel. A detailed study of 642 patients. Gastroenterology 1976;70:22-8.
2. Annese V, Bassotti G, Napolitano G, Frusciante V, Bruno M, Conoscitore P et al. Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol 1995;21:279-82.
3. Grill BB, Lange R, Markowitz R, Hillemeier AC, McCallum RW, Gryboski JD. Delayed gastric emptying in children with Crohn's disease. J Clin Gastroenterol 1985;7:216-26.
4. Keller J, Beglinger C, Holst JJ, Andresen V, Layer P. Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2009;297:G861-8.
5. Nobrega AC, Ferreira BR, Oliveira GJ, Sales KM, Santos AA, Nobre ESMA et al. Dyspeptic symptoms and delayed gastric emptying of solids in patients with inactive Crohn's disease. BMC Gastroenterol 2012;12:175.
6. Dew MJ, Harries AD, Rhodes M, Rhodes J, Leach KG. Gastric emptying after intestinal resection in Crohn's disease. Br J Surg 1983;70:92-3.
7. Damiao AO, Sipahi AM, Vezozzo DP, Goncalves PL, Laudanna AA. Measurement of gastric emptying time by real-time ultrasonography in patients with Crohn's disease. Rev Hosp Clin Fac Med Sao Paulo 1996;51:154-6.
8. Tomita R, Fujisaki S, Tanjoh K. Gastric emptying function after ileal J pouch-anal anastomosis for ulcerative colitis. Surgery 2004;135:81-6.
9. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013;108:18-37.
10. Liebregts T, Adam B, Bredack C, Gururatsakul M, Pilkington KR, Brierley SM et al. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am J Gastroenterol 2011;106:1089-98.
11. Nadorra R, Landing BH, Wells TR. Intestinal plexuses in Crohn's disease and ulcerative colitis in children: pathologic and microdissection studies. Pediatr Pathol 1986;6:267-87.
12. Lindgren S, Lilja B, Rosen I, Sundkvist G. Disturbed autonomic nerve function in patients with Crohn's disease. Scand J Gastroenterol 1991;26:361-6.
13. Fraser RJ, Horowitz M, Maddox AF, Harding PE, Chatterton BE, Dent J. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990;33:675-80.
14. Voiosu T, Bengus A, Dinu R, Voiosu AM, Balanescu P, Baicus C et al. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study. J Gastrointestin Liver Dis 2014;23:273-8.
15. Peyrin-Biroulet L, Reinisch W, Colombel JF, Mantzaris GJ, Kornbluth A, Diamond R et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut 2014;63:88-95.
16. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
17. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298:82-6.
18. Delbende B, Perri F, Couturier O, Leodolter A, Mauger P, Bridgi B et al. 13C-octanoic acid breath test for gastric emptying measurement. Eur J Gastroenterol Hepatol 2000;12:85-91.
19. Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993;104:1640-7.
20. Keller J, Andresen V, Wolter J, Layer P, Camilleri M. Influence of clinical parameters on the results of C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil 2009;21:1039-e83.
21. Meier R, Hildebrand P, Thumshirn M, Albrecht C, Studer B, Gyr K et al. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. Gastroenterology 1990;99:1757-62.
22. Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 1994;43:535-9.
23. Deacon CF, Pridal L, Klarskov L, Olesen M, Holst JJ. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol 1996;271:E458-64.
24. Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, Hellstrom PM. Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY. Eur J Gastroenterol Hepatol 2005;17:207-12.
25. Curran-Everett D, Benos DJ. Guidelines for reporting statistics in journals published by the American Physiological Society. Physiol Genomics 2004;18:249-51.
26. Niederau C, Luthen R, Heintges T. Effects of CCK on pancreatic function and morphology. Ann N Y Acad Sci 1994;713:180-98.
27. Beglinger C. Effect of cholecystokinin on gastric motility in humans. Ann N Y Acad Sci 1994;713:219-25.
28. Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. DigDis Sci 1995;40:1074-82.
29. Keller J, Holst JJ, Layer P. Inhibition of human pancreatic and biliary output but not intestinal motility by physiological intraileal lipid loads. Am J Physiol Gastrointest Liver Physiol 2006;290:G704-9.
30. Moran GW, Pennock J, McLaughlin JT. Enteroendocrine cells in terminal ileal Crohn's disease. J Crohns Colitis 2012;6:871-80.
31. Witte AB, Gryback P, Jacobsson H, Naslund E, Hellstrom PM, Holst JJ et al. Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion. Scand J Gastroenterol 2011;46:428-35.
32. Steinert RE, Schirra J, Meyer-Gerspach AC, Kienle P, Fischer H, Schulte F et al. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men. Am J Clin Nutr 2014;100:514-23.
33. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut 2005;54(Suppl 6):vi1-28.
34. Kristinsson JO, Hopman WP, Oyen WJ, Drenth JP. Gastroparesis in patients with inactive Crohn's disease: a case series. BMC Gastroenterol 2007;7:11.
35. Kohno N, Nomura M, Okamoto H, Kaji M, Ito S. The use of electrogastrography and external ultrasonography to evaluate gastric motility in Crohn's disease. J Med Invest 2006;53:277-84.
36. Rao SS, Read NW. Gastrointestinal motility in patients with ulcerative colitis. Scand J Gastroenterol Suppl 1990;172:22-8.
37. Nair NS, Brennan IM, Little TJ, Gentilcore D, Hausken T, Jones KL et al. Reproducibility of energy intake, gastric emptying, blood glucose, plasma insulin and cholecystokinin responses in healthy young males. Br J Nutr 2009;101:1094-102.
38. Hauser B, De Schepper J, Caveliers V, Salvatore S, Salvatoni A, Vandenplas Y. Variability of the 13C-octanoic acid breath test for gastric emptying of solids in healthy children. Aliment Pharmacol Ther 2006;23:1315-9.
39. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997;112:1155-62.
40. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998;93:92-8.
41. Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut 1996;39:299-305.